No Data
Morgan Stanley Maintains Zoetis(ZTS.US) With Buy Rating, Maintains Target Price $248
Morgan Stanley analyst Erin Wright maintains $Zoetis(ZTS.US)$ with a buy rating, and maintains the target price at $248.According to TipRanks data, the analyst has a success rate of 65.4% and a total
Express News | Lifecome Biochemistry: signed a supply agreement with Solvay Belgium.
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.
Global Veterinary Pain Management Market Report 2024-2032, Featuring Assisi Animal Health, Bayer, Chanelle Pharma, Dechra Pharmaceuticals, Eli Lilly, Idexx Laboratories, Norbrook, Vetoquinol & Zoetis
Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to co
Is Zoetis Stock Underperforming the Nasdaq?